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ABSTRACT
Introduction: Corticosteroid injections (CSI) are
a recommended and often-used ﬁrst-line intervention
for shoulder impingement syndrome (SIS) in primary
care and orthopaedic settings. Manual physical therapy
(MPT) offers a non-invasive approach with negligible
risk for managing SIS. There is limited evidence to
suggest signiﬁcant long-term improvements in pain,
strength and disability with the use of MPT, and there
are conﬂicting reports from systematic reviews that
question the long-term efﬁcacy of CSI. Speciﬁcally, the
primary objective is to compare the effect of CSI and
MPT on pain and disability in subjects with SIS at
12 months.
Design: This pragmatic randomised clinical trial will
be a mixed-model 235 factorial design. The
independent variables are treatment (MPT and CSI)
and time with ﬁve levels from baseline to 1 year. The
primary dependent variable is the Shoulder Pain and
Disability Index, and the secondary outcome measures
are the Global Rating of Change and the Numeric Pain
Rating Scale. For each ANOVA, the hypothesis of
interest will be the two-way group-by-time interaction.
Methods and analysis: The authors plan to recruit
104 participants meeting established impingement
criteria. Following examination and enrolment, eligible
participants will be randomly allocated to receive
a pragmatic approach of either CSI or MPT. The MPT
intervention will consist of six sessions, and the CSI
intervention will consist of one to three sessions. All
subjects will continue to receive usual care. Subjects
will be followed for 12 months.
Dissemination and ethics: The protocol was
approved by the Madigan Army Medical Center
Institutional Review Board. The results may have an
impact on clinical practice guidelines. This study was
funded in part by the Orthopaedic Physical Therapy
Products Grant through the American Academy of
Orthopaedic Manual Physical Therapists.
Trial Registration: http://clinicaltrials.gov/
NCT01190891.
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ARTICLE SUMMARY
Article focus
- Shoulder pain is a common symptom in patients
seeking healthcare for musculoskeletal
complaints.
- Corticosteroid injections (CSI) are a common
ﬁrst-line intervention for shoulder pain in primary
care settings, but their long-term efﬁcacy has not
been established.
- The long-term efﬁcacy of manual physical
therapy and CSI will be evaluated and compared
from baseline out to 1 year after enrollment.
Key messages
- Manual physical therapy has been shown to
provide improvements in pain and function in
patients with shoulder impingement but has not
been directly compared with CSI.
- Understanding which interventions have better
long-term outcomes may be instrumental in
helping improve clinical practice guidelines for
the management of shoulder impingement
syndrome.
Strengths and limitations of this study
- This randomised controlled study will compare
the effectiveness of a manual physical therapy
approach to a corticosteroid injection in patients
with shoulder impingement.
- This is a pragmatic study evaluating two
interventions that are standard practice and
have been shown to be effective for shoulder
impingement.
- Even as a single blinded randomised clinical trial
there is no true control group, and we cannot
state whether true a cause-and-effect relation-
ship exists.
- Owing to the pragmatic nature of the study, the
intervention will not be standardised, which
could make it difﬁcult for clinicians to replicate.
- The lack of a gold standard with the diagnosis of
shoulder impingement makes this population
difﬁcult to study.
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Open Access ProtocolINTRODUCTION
Shoulder impingement is among the most common
function-limiting disorders of the musculoskeletal
system.
1 2 The point prevalence of shoulder symptoms
has been reported to range from 20 to 33%,
3 and the
incidence of shoulder complaints in the general popu-
lation is increasing.
4 Furthermore, several authors have
reported low rates of perceived recovery (patient reports
of ‘being cured’) for patients with a new episode of
shoulder pain.
4e7 Less than 25% of patients with a ﬁrst
episode of shoulder pain may recover and be symptom-
free after 3 months.
5 Recovery rates at 18 months have
been reported only between 49% and 59%,
568and 25%
of patients with shoulder or neck pain experience at
least one episode of recurrence within 12 months.
9
These ﬁndings suggest that shoulder pain can be
recurrent and frequently progresses to the chronic stage.
A comprehensive manual physical therapy (MPT)
approach, including both thrust and non-thrust tech-
niques and reinforcing mobility exercises, is a common
intervention for patients presenting with a primary
report of shoulder pain.
1 9e16 This comprehensive
approach has shown improvement in shoulder symp-
toms with mobilisation and manipulation techniques
targeted to the thoracic spine, cervicothoracic spine, rib
cage and acromioclavicular joints,
91 2in addition to the
glenohumeral joint. A recent systematic review by Ho
et al
17 stated there was no clear evidence to suggest
additional beneﬁts of manual therapy to other inter-
ventions for shoulder impingement, indicating the need
for further high-quality research. That systematic review
was conducted through January of 2007, excluding some
more recent trials discussed below.
In a trial by Bergman et al,
10 patients with a primary
report of shoulder pain were randomly assigned to
receive usual medical care for their shoulder symptoms
from their primary care physicians or usual care plus
manipulative therapy (UMC+MT) directed at the cervi-
cothoracic spine and rib cage for a maximum of six
treatment sessions. The group that received manipula-
tive therapy reported increased rates of ‘full recovery’,
and improved disability out to 52 weeks.
10 In a trial by
Bang and Deyle,
9 signiﬁcant improvements in function
and pain with the use of an MPTapproach, consisting of
manual techniques and reinforcing exercises, were seen
out at 2 months. Two other studies compared the use
of manual mobilisation techniques in addition to
a comprehensive offering of various therapeutic modal-
ities and exercise, and showed improved outcomes in the
groups that received mobilisations in addition to their
comprehensive programme.
10 18 Several other studies
have looked at a less pragmatic approach to manual
therapy by breaking down the manual therapy approach
into several subcomponents.
18 19 No evidence for harm
with using this intervention has been reported.
Corticosteroids injections are a common intervention
for symptoms from shoulder impingement and have also
been shown to be an effective treatment for shoulder
pain. They are one of the most common procedures for
the management of shoulder pain used by orthopaed-
ists, rheumatologists and general practitioners,
20 with
96% of clinicians in a recent survey stating that CSI is an
efﬁcacious treatment option for rotator cuff pathology.
21
Conﬂicting evidence in the literature suggests their
efﬁcacy in the management of shoulder impingement is
not well established.
22e27 A recent meta-analysis by
Arroll and Goodyear-Smith
23 evaluating the efﬁcacy of
CSI for painful shoulder conditions (included rotator
cuff tendonitis and adhesive capsulitis) concluded that
subacromial injections are probably effective for
improvement of rotator cuff tendonitis when compared
with placebo or non-steroidal anti-inﬂammatory drugs,
but that there is still insufﬁcient evidence to determine
the extent of their effectiveness. Five studies compared
subacromial injection with placebo and showed signiﬁ-
cantly better results then placebo in all studies,
28 but
only three of those studies were speciﬁcally for shoulder
impingement. The determination of effectiveness was
based on dichotomising results into success and non-
success based on the terms that included ‘responder,’
‘decreased pain’ and ‘remission.’
A recent Cochrane review
24 and a meta-analysis by
Gaujoux-Viala et al
26 indicated that steroid injections
were not more effective than non-steroidal anti-inﬂam-
matory drugs in the treatment of shoulder and elbow
tendonitis. Another review by Koester et al
27 found nine
randomised clinical trials comparing subacromial corti-
costeroid injection with placebo in patients with rotator
cuff disease and concluded that subacromial corticoste-
roid injection is not effective for the treatment of rotator
cuff disease. It has been reported that the variable
success with subacromial CSI may be due to inaccuracy
of the clinician in terms of approach (posterior or
anterolateral),
29 tendon penetration
30 and/or inconsis-
tencies in dose.
23
Speciﬁc aim
The aim was to determine if there is any clinically
signiﬁcant difference in outcomes of pain and disability
between subjects with shoulder impingement syndrome
that receive MPT compared with CSI at 1 year.
TRIAL DESIGN AND METHODS
The study will be a randomised clinical trial. The inde-
pendent variables are treatment (MPT and CSI) and
time with ﬁve levels from baseline out to 1 year. The
primary dependent variable (DV) is the Shoulder Pain
and Disability Index (SPADI). The secondary DVs are
the Global Rating of Change (GRC) and the Numeric
Pain-Rating Scale (NPRS). Figure 1 demonstrates the
ﬂow of subjects through the trial. This will be a trial
assessing pragmatic delivery of two common interven-
tions, and will report results following CONSORT
guidelines for pragmatic trials.
31 The current SPIRIT
guidelines for creating protocols for randomised clinical
trials were followed.
32
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Pragmatic care for shoulder impingement; protocol for an RCTParticipants
We will recruit 104 subjects, male and female, between
the ages of 18 and 65 years with a primary complaint of
shoulder pain through the Physical Therapy departments
at Madigan Army Medical Center as well as the outlying
primary care clinics on the military installation. They will
be recruited through the referral source to Physical
Therapy from outlying clinics (Family Practice, Ortho-
paedics and Primary Care clinics). If recruitment targets
are not being met, ﬂyers with information about the
study may be distributed for potential subjects to enquire
about, as patients in this setting have direct access to
physical therapy care and do not need a referral source.
Inclusion criteria:
1. Age 18 and older.
2. Read, write, and speak English.
3. Eligible for healthcare at a military medical treatment
facility.
4. Primary complaint of shoulder pain (glenohumeral
region).
5. Meets diagnostic criteria for shoulder impingement
(mentioned below).
Exclusion criteria:
1. History of a shoulder injection for the current
episode of pain.
2. History of shoulder dislocation, subluxation, frac-
ture, adhesive capsulitis the glenohumeral joint or
cervical/shoulder/upper back surgery.
3. Isolated acromioclavicular joint (ACJ) pathology.
The only location of symptoms is localised speciﬁcally
with one ﬁnger directly over the ACJ and nowhere
else, and reproduced only with ACJ palpation by the
examiner.
4. Full-thickness rotator cuff tears (evidenced by MRI
and/or positive lag signs).
5. Presence of cervical radiculopathy, radiculitis, or
referral from cervical spine.
6. Total baseline SPADI score not <20% (to prevent
a ceiling effect with treatment).
7. History of breast cancer on the involved side.
8. Prior MPT treatment to the involved limb for the
current episode of pain.
9. Military service members pending a medical evalua-
tion board, physical evaluation board or equivalent
discharge process, or in medical hold to determine
long-term disposition. For non-military personnel,
anyone who is pending or undergoing any litigation
for their injury.
10. Contraindications or precautions to receiving a corti-
costeroid injection (history of allergies, adverse
reactions, history of multiple injections in that area
even if not within last 30 days, uncontrolled diabetes
mellitus, pregnancy, etc).
11. Unable to give informed consent to participate in
the study.
12. Unable to come into the clinic for regular treatment
over the course of the following month.
Diagnostic criteria for entry:
To be included in the study, participants are required
to have:
1. Pain with one of the two tests in category I; and
2. Pain with one test from either category II or category
III.
with ‘pain’ being deﬁned as reproduction of the usual
pain that the subject experiences that makes up the
nature of their complaint.
Category I: impingement signs:
1. Passive overpressure at full shoulder ﬂexion with the
scapula stabilised.
2. Passive internal rotation at 908 of shoulder ﬂexion in
the scapular plane and in progressive degree of
horizontal adduction.
Category II: active shoulder abduction:
Active shoulder abduction
Category III: resisted break tests:
1. Abduction
2. Internal rotation
3. External rotation
These criteria have been used in previous clinical trials
to classify patients with shoulder impingement
syndrome.
17 23
Randomisation
Once the baseline examination is completed, a second
investigator blind to the baseline examination will
open the randomisation envelope indicating the
Figure 1 Proposed recruitment ﬂow of the study. CSI,
corticosteroid injection; GRC, Global Rating of Change; NPRS,
Numeric Pain Rating Scale; MPT, Manual Physical Therapy;
SPADI, Shoulder Pain and Disability Index.
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Pragmatic care for shoulder impingement; protocol for an RCTpatient’s treatment group assignment that corresponds
to the patient’s unique identiﬁcation number. A
random-number generator will be used to establish
randomisation lists prior to the initiation of the study.
Individual randomisation assignments will be concealed
according to the following procedure. The group
assignment will be recorded on a label that is afﬁxed to
a 3.535 inch index card. This card will be folded in half
such that the label with the patient‘s group assignment
will be on the inside of the fold. The folded index card
will then be placed inside the envelope, and the enve-
lope will be sealed. This will prevent the possibility of the
therapist holding the envelope up to the light and
visualising the patient’s treatment group assignment
through a sealed yet transparent envelope.
Blinding
Owing to the nature of this study, it is not possible to
blind the patient or the clinician providing the inter-
vention to the treatment received. The clinician
performing the screening, baseline and follow-up
measurements, and outcome assessments will be blinded
to the patient’s treatment group assignment. Patients
will be instructed not to discuss the intervention received
with the clinician when reporting for their follow-up
appointments unless medically necessary. Incidence of
unmasking will be recorded.
Interventions
Both treatment options are standard-of-care interventions.
Their allocation and dosage are described in table 1.
Manual physical therapy
At the ﬁrst session, the examiner will perform a stand-
ard clinical examination in order to determine the
appropriate application and delivery of MPT (appendix 1)
to the entire shoulder, spine, and adjacent joints. The
goal of MPT is to improve the quality of motion and
decrease the pain associated with motion at the target
joint and soft tissue. For our purposes, we deﬁne our
MPT as the combination of manual techniques to
include joint mobilisations (both thrust and non-thrust
techniques), soft-tissue mobilisations, manual stretches
and contracterelax techniques, along with the exercises
that help reinforce those techniques. We feel this is
consistent not only with other shoulder trials, but also
with other MPT trials.
9 33e35 The application of
techniques will not be based on a regimented protocol
that is identical for each patient, but rather tailored
speciﬁcally to the impairments identiﬁed during the
clinical examination. We feel this approach is pragmatic
and consistent with the actual delivery of MPT in the
clinical setting.
The examiner will provide an initial intervention of
MPT that is targeted to impairments found during the
initial clinical examination (the patient will return for
a maximum total of six treatment sessions over the
following 3 weeks). Each session will last approximately
30 min. The subjects will receive some of the protocol
exercises (appendix 2) to augment the joint mobi-
lisations, which will collectively make up the MPT
intervention.
The clinicians providing the MPT are two fellowship-
trained orthopaedic manual physical therapists, who
both received training in the same 18-month programme,
to ensure consistency with delivery of this intervention
approach.
Corticosteroid injection
The examiner will perform a standardised clinical
examination and health screening in order to conﬁrm
the absence of contraindications to steroid injection.
The subject will then receive an injection in the suba-
cromial space of the symptomatic shoulder by a senior
Sports Medicine Fellowship Trained Family Physician
(appendix 3). The subject will also receive a handout
explaining the effects of the steroid injection and how to
manage any potential ﬂare-ups or ensuing pain, and
a handout describing pendulum exercises for the subject
to perform. The physician will spend approximately
30 min with each subject explaining the rationale for the
injection, relevant anatomy, performing the procedure
and reviewing the pendulum exercises.
The subject can receive up to a total of two shoulder
injections with a minimum of 1 month between injec-
tions if they are not getting relief of symptoms with the
initial injection. This will be dictated by patient prefer-
ence and the approval/recommendation of the physi-
cian performing the injection procedure, as this would
represent a pragmatic approach commensurate with
standard practice.
Outcome measures
The primary DV will be the SPADI, and the secondary
DVs will be the GRC and the NPRS.
Shoulder Pain and Disability Index
SPADI is a 100-point, 13-item self-administered ques-
tionnaire, divided into two subscales: a ﬁve-item pain
subscale and an eight-item disability subscale. Williams
Table 1 Treatment allocation and dosage
Intervention Subjects needed Dosage
Follow-up time points
(months)
Corticosteroid injection N¼52 One initially; option for a total
of three within ﬁrst 6 months
1, 3, 6, 12
Manual physical therapy N¼52 Six sessions 1, 3, 6, 12
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Pragmatic care for shoulder impingement; protocol for an RCTet al have shown that the SPADI is responsive to change
and accurately discriminates between patients who are
improving or worsening.
36 A high testeretest reliability
and internal consistency for this instrument has been
reported.
37 A recent systematic review identiﬁed
a minimal detectable change of 18 points and a mini-
mally clinically important difference (MCID) of 8e13
points.
38 The validity and responsiveness to change of
SPADI have been described in physical therapy, as well as
primary- and secondary-care settings.
39
Because disability will be used as an outcome of
interest, it is important to ensure a moderate level of
disability will be present at the inception of the treat-
ment. Thus, patients will be required to have at least
a baseline SPADI score of 20 points (average of pain and
disability subscales). A score of 0 indicates no pain or
functional limitation with the described activities.
Global Rating of Change questionnaire
The GRC questionnaire is an instrument that measures
overall changes in the quality of life of the subject.
40 The
use of a GRC is a common, feasible and useful method
for assessing outcome,
41 and has been shown to be
a valid measurement of change in patient status in other
pain populations.
42 A change in score of three rating
points (+3) has been established as clinically signiﬁcant
in the patients perception of quality of life.
41 The
GRC has 15 possible choices, with 0 being equal to no
change,  1t o 7 indicating a negative change and +1
to +7 indicating a positive change.
Numeric Pain-Rating Scale
An 11-point pain-rating scale ranging from 0 (no pain)
to 10 (worst imaginable pain) will be used to assess pain
intensity in the shoulder.
43 This scale has been demon-
strated to be reliable and generalisable, and to have
internal consistency in measures of clinical and experi-
mental pain sensation intensity.
44 45 A change of at least
three points has been suggested as the MCID for the
NPRS in patients with shoulder pain.
46
Justiﬁcation of sample size
The calculations were based on detecting a 12-point (or
9.2% changedbased on reported MCID range of 8e13
points)
38 difference in the SPADI with a standard devi-
ation of 10 points, a two-tailed test and an a level ¼0.05.
This generates a sample size of 43 subjects per group.
Allowing for a conservative dropout or loss to follow-up
rate of approximately 20%, we will recruit 104 subjects
into the study. Planning for a larger loss to follow-up rate
is deemed necessary in this military population where
follow-up at 1 year can be challenging with multiple
deployments and changes in duty station around the
world. This sample size will yield greater than 80% power
to detect both statistically signiﬁcant and clinically
meaningful changes in the other outcome variables.
Sample-size estimation was performed with G*Power
software, V 3.1.2.
47
Data analysis
Descriptive statistics will be run on the demographic data
(age, gender, race, etc) and health characteristics of the
study population to include measures of central
tendency (means, medians other percentiles) and
dispersion (standard deviations, ranges) which will be
computed for continuous data for summary. Frequency
distributions will be estimated for categorical data.
Graphical displays including histograms and box plots
will be produced. Transformations will be sought for
variables to be included in further analyses to ensure
distributional assumptions are met.
We will examine the primary aim using a linear mixed
model with repeated measures to account for the
correlation among repeated observations from the same
patient. Time (baseline, 1, 3, 6 and 12 months) and
treatment group (MPT and CSI) will be modelled as
ﬁxed effects, with the SPADI questionnaire as the
primary dependent variable. A separate model will be
constructed in a similar fashion with pain (NPRS) and
the GRC as the DV. The hypothesis of interest will be the
group-by-time interaction. Treatment effects will be
calculated from the between-group differences in
change score from baseline to 1, 3, 6 and 12 months. No
patients will be removed from the analysis for lack of
adherence to treatment procedures. Missing data points
will be estimated in the mixed model analyses using
restricted maximum likelihood ratio estimation with 100
iterations. If one treatment is shown to be superior to
the other, supplemental analyses will be performed by
dichotomising groups based on minimal clinically
important differences of 13% for the SPADI.
45 This will
allow computation of absolute risk reduction, relative
risk reduction and number needed to treat (with asso-
ciated 95% CIs) using failure to obtain clinically mean-
ingful beneﬁt as the event of interest. The level of
signiﬁcance for all analyses will be a priori established at
0.05 using a two-tailed test.
Because of potential crossover between groups, data
will be analysed using both per-protocol and intention-
to-treat principles. The per-protocol analyses will only
include patients who completed the study in the group
to which they were randomly assigned. The intention-to-
treat analyses will include all patients who were rando-
mised at baseline regardless if they crossed over. Data
analysis will be conducted using SPSS for Windows V 16.
Trial organisation and monitoring
The investigative team includes the authors listed in this
protocol, in addition to three other licensed physical
therapists who will assist with subject screening, data
collection, subject follow-up and data entry. The principal
investigator will manage data ﬂow and perform audits of
the procedures, enrolment and treatment throughout
the entire process of the study. The associate investigators
will monitor the data-collection process and data integrity
with periodic evaluation performed continually during
the course of the data-collection phase.
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Pragmatic care for shoulder impingement; protocol for an RCTDISCUSSION
This randomised clinical trial will be the ﬁrst study that
directly compares the short- and long-term effects of an
impairment-based MPT approach and CSI for patients
with shoulder impingement syndrome. The results of
this study may help to establish best clinical practice
guidelines for this patient population.
ETHICAL CONSIDERATIONS AND DISSEMINATION
All interventions provided in this study are considered
standard of care and could be given to a patient as part
of their treatment plan even if they were not part of this
study. An ethics review will be conducted by Madigan
Army Medical Center and monitored by the US Army
Medical Department Clinical Investigation Regulatory
Ofﬁce to ensure compliance with federal regulations for
protection of human medical research subjects. This
clinical trial was registered with http://clinicaltrials.gov/
with a registration number of NCT01190891.
PUBLICATION POLICY
The results of the trial will be published in an appro-
priate journal regardless of outcome. We will report the
results following the CONSORT statement with the
recommended extension for pragmatic trials.
31
PROJECTED TIMETABLE FOR TRIAL
March 2010dprotocol approved by the Western
Regional Medical Command Institutional Review Board.
June 2010dsubject enrolment begins.
June 2011dﬁrst subject completes 1-year follow-up.
July 2011dsubject enrolment complete.
July 2012dlast subject completes 1-year follow-up.
December 2012ddata entry and analysis complete.
June 2013dpublication with study results submitted
for publication.
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